| Glucose Metabolism Disorders |
TOPLEVEL, NCT02449330: Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study |
|
|
| Recruiting | 4 | 936 | Japan | Teneligliptin | National Cerebral and Cardiovascular Center | Diabetes Mellitus, Type 2 | 06/20 | 06/23 | | |
NCT00923715: Exenatide (Byetta) Versus Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia |
|
|
| Enrolling by invitation | 3 | 63 | US | Insulin, Insulin and Exenatide, Insulin and Pramlintide | Baylor College of Medicine, Albert Einstein College of Medicine of Yeshiva University | Diabetes Mellitus, Type 1 | 12/11 | 05/12 | | |
| | 2 | 24 | US | Glutamine, Glutamine Dipeptide, Placebo, Surgery | Ziegler, Thomas R., M.D. | Stress Hyperglycemia, Insulin Resistance, Trauma, Critical Illness | 07/13 | 02/14 | | |
Steno-2, NCT00320008: Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria |
|
|
| Active, not recruiting | N/A | 160 | Europe | Diet, Exercise, Stop smoking, Glucose lowering therapy, Blood pressure lowering therapy, Lipid lowering therapy | Peter Gæde | Type 2 Diabetes | 12/01 | 12/25 | | |
NCT00005130: Coronary Artery Risk Development in Young Adults |
|
|
| Active, not recruiting | N/A | 5115 | NA | | National Heart, Lung, and Blood Institute (NHLBI) | Cardiovascular Diseases, Coronary Disease, Hypertension, Heart Diseases, Obesity, Diabetes Mellitus | 06/33 | 06/33 | | |
NCT00965315: A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome |
|
|
| Available | N/A | | RoW | Rosuvastatin,SFC fenofibrate | National Taiwan University Hospital | Diabetes, CVD | | | | |
NCT00948493: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes |
|
|
| No Longer Available | N/A | | US | Buccal insulin spray, Generex Oral-lynTM (oral, buccal insulin spray) | Generex Biotechnology Corp. | Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | | | | |
NCT01049633: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure |
|
|
| No Longer Available | N/A | | US | Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab, Tacrolimus, Antibacterial, Antifungal, and Antiviral Prophylaxis, Trimethoprim/sulfamethoxazole, Septra SS, Clotrimazole, Mycelex Troche, Valganciclovir, Valcyte, Heparin, Anticoagulation and Hematological Agent, Enoxaparin, Lovenox; Anticoagulation and Hematological Agent, Pentoxifylline, Aspirin, ASA | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | | | | |
| Available | N/A | | RoW | Abroma Augusta Q (mother tincture), Abroma Augustum, | Fr Muller Homoeopathic Medical College | Type II Diabetes Mellitus | 12/14 | 12/14 | | |
NCT01798914: Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder |
|
|
| No Longer Available | N/A | | US | Technosphere Insulin Inhalation Powder, Afrezza Inhalation Powder | Mannkind Corporation | Type 1 Diabetes, Type 2 Diabetes | 04/15 | 05/15 | | |
NCT02008188: Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes (Italy) |
|
|
| Active, not recruiting | N/A | 12 | Europe | Closed Loop Control with the Advisory/Automated Adaptive (AAA) Control system | University of Virginia, National Institutes of Health (NIH) | Type 1 Diabetes Mellitus | 05/15 | 05/15 | | |
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911) |
|
|
| No Longer Available | N/A | | US | Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic® | National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN) | Diabetes Mellitus, Type 1 | | | | |
| | N/A | 120 | US | Exercise training protocol, cardio, resistance training, Dietary, diet, nutrition, Educational control., education, behavioral | University of Pittsburgh, National Institute on Aging (NIA) | Aging | 09/16 | 09/16 | | |
NCT01883154: The Impact of Placental Factors on Fetal Intrauterine Growth and in Intrauterine Programming of the Metabolic Syndrome |
|
|
| Not yet recruiting | N/A | 160 | RoW | | Meir Medical Center | Normal Pregnancies | 09/17 | 09/23 | | |
ECHO, NCT03062072: Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients |
|
|
| Recruiting | N/A | 300 | RoW | Chemotherapy, cytotoxic chemotherapeutic agents | National Cancer Center, Korea, SMG-SNU Boramae Medical Center | Cancer, Colon Cancer, Breast Cancer, Malignant Lymphoma | 12/17 | 12/22 | | |
NCT02836808: Validation of an Integrated Attention Model for Patients With Type 2 Diabetes |
|
|
| Recruiting | N/A | 1200 | RoW | CAIPaDi | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Type 2 Diabetes | 02/18 | 12/28 | | |
NCT02950324: Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer? |
|
|
| Not yet recruiting | N/A | 50 | Europe | Prehabilitation, Standard care | Royal Surrey County Hospital NHS Foundation Trust | Cancer | 11/18 | 11/22 | | |
| Recruiting | N/A | 400 | RoW | Blood sampling | University of Malaya | Metabolic Syndrome X | 12/18 | 12/24 | | |
| Enrolling by invitation | N/A | 80 | Europe | | Oslo University Hospital, Aarhus University Hospital | Diabetes Mellitus, Pancreas Transplantation, Allograft Rejection, Surgical Complication Nec, Allograft Biopsies | 04/19 | 10/28 | | |
NCT02035891: Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria |
|
|
| Active, not recruiting | N/A | 160 | RoW | colchicine 0.5mg/d, placebo 0.5mg/d | Chongqing Medical University | Diabetic Nephropathy | 09/19 | 06/23 | | |
| Recruiting | N/A | 500 | RoW | | Hospital Regional de Alta Especialidad del Bajio | Diabetes Mellitus | 12/20 | 12/30 | | |
| Active, not recruiting | N/A | 366 | Europe | Pre-diabetes screening | Nantes University Hospital | Pre-diabetes | 06/23 | 06/23 | | |
| Active, not recruiting | N/A | 56 | Europe | LSG, CMT | Stefano Trastulli, Ethicon Endo-Surgery | Type 2 Diabetes Mellitus | 03/28 | 03/28 | | |
NCT01055093: Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients |
|
|
| Recruiting | N/A | 2000 | Europe | | German Diabetes Center | Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 09/25 | 09/35 | | |
| Enrolling by invitation | N/A | 2246 | Europe | Individual treatment, mulitinterventional | Odense University Hospital, Region of Southern Denmark, Hospital of South West Denmark, General Practice Research Database | Type 2 Diabetes, Hypertension | 10/25 | 10/25 | | |
NCT02726256: G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance) |
|
|
| Not yet recruiting | N/A | 500 | RoW | | Yonsei University | Type 2 Diabetes, Impaired Glucose Intolerance | 02/26 | 02/26 | | |
| Not yet recruiting | N/A | 1000 | Europe | Tacrolimus once daily (Advagraf), mycophenolate, steroids | Klemens Budde, Dr. med. univ. L. J. Lehner, Charite University, Berlin, Germany, ERA-EDTA, DESCARTES Working Group On Transplantation, European Kidney Transplant Association (EKITA) | Graft Failure, Death, Acute Rejection of Renal Transplant, Infections, Bone Disease, Post Transplant Diabetes Mellitus, Quality of Life, HLA Antibody Production, Cardiovascular Risk Factors, Non-HLA Antibody Production | 01/27 | 01/28 | | |
NCT02967406: Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population |
|
|
| Active, not recruiting | N/A | 3600 | RoW | 4 x 4 lifestyle modification | Sanpasitthiprasong Hospital, Dementia Association of Thailand, Diabetes Association of Thailand, The Endocrine Society of Thailand, Nephrology Society of Thailand, Thai Dietetic Society, Ubon Ratchathani Public Health Office, Thailand | Dementia, Diabetes Mellitus, Chronic Kidney Disease, Cardiovascular Diseases, Malignancy, Chronic Obstructive Pulmonary Disease | 03/27 | 08/27 | | |
NCT02569151: 20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up |
|
|
| Not yet recruiting | N/A | 600 | Japan | HBP & CBP measurement using systo 130 mmHg | Kyuzi Kamoi | Diabetes Mellitus | 03/27 | 04/27 | | |
| Recruiting | N/A | 500 | Europe | No interventions are planned for this study. | Heidelberg University | Diabetes Complications | 09/27 | 09/28 | | |
| Recruiting | N/A | 2000 | Europe | Fibrosis Biomarkers, AST:ALT ratio, APRI, BARD score, ELF Score, FIB4, NAFLD Fibrosis Score,Transient Elastography | University of Nottingham | Chronic Liver Disease, Alcohol Use Disorder, Type 2 Diabetes, Persistently Elevated ALT, Obesity | 05/33 | 05/33 | | |
NCT01386801: Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana |
|
|
| Active, not recruiting | N/A | 1000 | US | | Fairbanks Institute, Indiana University School of Medicine, Richard M. Fairbanks Foundation, BioCrossroads, Regenstrief Institute, Inc. | Diabetes Mellitus Type II | 12/49 | 06/50 | | |
NCT01779115: Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel |
|
|
| Enrolling by invitation | N/A | 126000 | RoW | | Maccabi Healthcare Services, Israel | Type 1 Diabetes, Type 2 Diabetes | 12/00 | | | |
